Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hpv vaccine AND:

Search results

Items: 1 to 20 of 10458

  • The following term was ignored: AND
  • See the search details.
1.

Anogenital Human Papillomavirus Virus DNA and Sustained Response to the Quadrivalent HPV Vaccine in Women Living with HIV-1.

Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA.

Papillomavirus Res. 2018 Aug 15. pii: S2405-8521(18)30040-5. doi: 10.1016/j.pvr.2018.08.002. [Epub ahead of print]

PMID:
30118852
2.

HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia.

Simas C, Munoz N, Arregoces L, Larson HJ.

Hum Vaccin Immunother. 2018 Aug 17. doi: 10.1080/21645515.2018.1511667. [Epub ahead of print]

PMID:
30118381
3.

Determinants of attitudes and beliefs toward human papillomavirus infection, cervical cancer and human papillomavirus vaccine among parents of adolescent girls in Mysore, India.

Degarege A, Krupp K, Srinivas V, Ibrahimou B, Marlow LAV, Arun A, Madhivanan P.

J Obstet Gynaecol Res. 2018 Aug 16. doi: 10.1111/jog.13765. [Epub ahead of print]

PMID:
30117218
4.

The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.

Skufca J, Ollgren J, Artama M, Ruokokoski E, Nohynek H, Palmu AA.

Vaccine. 2018 Jul 25. pii: S0264-410X(18)30925-3. doi: 10.1016/j.vaccine.2018.06.074. [Epub ahead of print]

PMID:
30115524
5.

Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies.

Zhang Y, He Y, Li L, Liang S, Yan M, Ren D, Yang Z, Zhao W, Miao L, Zhang H, Liu Y.

Diagn Pathol. 2018 Aug 17;13(1):55. doi: 10.1186/s13000-018-0727-7.

PMID:
30115088
6.

Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary.

Menon S, Rossi R, Kariisa M, Callens S.

Virol J. 2018 Aug 16;15(1):129. doi: 10.1186/s12985-018-1039-y.

PMID:
30115083
8.

Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule.

Brotherton JM.

Aust J Gen Pract. 2018 Jul;47(7):417-421.

PMID:
30114867
9.

Identification of determinants associated with uptake of the first dose of the human papillomavirus vaccine in Denmark.

Amdisen L, Kristensen ML, Rytter D, Mølbak K, Valentiner-Branth P.

Vaccine. 2018 Aug 12. pii: S0264-410X(18)31113-7. doi: 10.1016/j.vaccine.2018.08.006. [Epub ahead of print]

PMID:
30111513
10.

Evaluation of the Implementation of a Multi-Component Intervention to Improve Healthcare Provider Communication about HPV Vaccination.

Reno JE, O'Leary ST, Pyrzanowski J, Lockhart S, Thomas J, Dempsey AF.

Acad Pediatr. 2018 Aug 11. pii: S1876-2859(18)30525-4. doi: 10.1016/j.acap.2018.08.004. [Epub ahead of print]

PMID:
30107236
11.

HPV vaccine safety: Cochrane launches urgent investigation into review after criticisms.

Hawkes N.

BMJ. 2018 Aug 9;362:k3472. doi: 10.1136/bmj.k3472. No abstract available.

PMID:
30101747
12.

Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5.

Wetherill LF, Wasson CW, Swinscoe G, Kealy D, Foster R, Griffin S, Macdonald A.

Antiviral Res. 2018 Aug 7;158:113-121. doi: 10.1016/j.antiviral.2018.08.005. [Epub ahead of print]

13.

Disparities in Human Papillomavirus Vaccine Completion Rates Among Females in an Integrated Health Care System.

Freeman AJH, Gamboa C, Darbinian JA, Littell RD, Torrente S.

Obstet Gynecol. 2018 Aug 6. doi: 10.1097/AOG.0000000000002802. [Epub ahead of print]

PMID:
30095768
14.

Social Determinants of Sexual Behavior and Awareness of Sexually Transmitted Infections (STI) Among Low-Income HIV+ or STI At-Risk Hispanic Residents Receiving Care at the U.S.-Mexico Border.

Tabler J, Mykyta L, Schmitz RM, Kamimura A, Martinez DA, Martinez RD, Flores P, Gonzalez K, Marquez A, Marroquin G, Torres A.

J Community Health. 2018 Aug 9. doi: 10.1007/s10900-018-0562-5. [Epub ahead of print]

PMID:
30094723
15.

Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.

Easterly CW, Alarid-Escudero F, Enns EA, Kulasingam S.

Vaccine. 2018 Aug 6. pii: S0264-410X(18)31065-X. doi: 10.1016/j.vaccine.2018.07.058. [Epub ahead of print]

PMID:
30093290
16.

Strengthening the Effectiveness of National, State, and Local Efforts to Improve HPV Vaccination Coverage in the United States: Recommendations From the National Vaccine Advisory Committee.

Approved by the National Vaccine Advisory Committee on June 25, 2018.

Public Health Rep. 2018 Aug 9:33354918793629. doi: 10.1177/0033354918793629. [Epub ahead of print]

PMID:
30091942
17.

VLP production from recombinant L1/L2 HPV-16 protein expressed in Pichia Pastoris.

Sanchooli A, Aghayipour K, Kiasari BA, Samarbaf-Zadeh A, Ghadiri A, Makvandi M.

Protein Pept Lett. 2018 Aug 9. doi: 10.2174/0929866525666180809124633. [Epub ahead of print]

PMID:
30091403
18.

Persistence of immunity when using different HPV vaccination schedules and booster dose effects at 5 years post-primary vaccination.

Lazcano-Ponce E, Torres-Ibarra L, Cruz-Valdez A, Salmerón J, Barrientos-Gutiérrez T, Prado-Galbarro J, Stanley M, Muñoz N, Herrero R, Hernández-Ávila M.

J Infect Dis. 2018 Aug 1. doi: 10.1093/infdis/jiy465. [Epub ahead of print]

PMID:
30085139
19.
20.

Factors Affecting Delivery of the HPV Vaccination: A Focus Group Study With NHS School-Aged Vaccination Teams in London.

Rockliffe L, McBride E, Heffernan C, Forster AS.

J Sch Nurs. 2018 Aug 5:1059840518792078. doi: 10.1177/1059840518792078. [Epub ahead of print]

PMID:
30079792

Supplemental Content

Loading ...
Support Center